Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis

Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis

Objective: Eosinophilic Otitis Media (EOM) is an intractable disease caused by type 2 inflammation, such as Eosinophilic Chronic Rhinosinusitis (ECRS) and bronchial asthma. Biologics have recently been used to treat ECRS and bronchial asthma. Biologics are not indicated for EOM; however, because app...

Full description

Saved in:

Bibliographic Details
Main Authors:	Seiichiro Kamimura, Keisuke Ishitani, Ryota Morozumi, Eiji Kondo, Takahiro Azuma, Go Sato, Yoshiaki Kitamura
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Brazilian Journal of Otorhinolaryngology
Subjects:	Eosinophilic otitis media Eosinophilic chronic rhinosinusitis Dupilumab Biologics
Online Access:	http://www.sciencedirect.com/science/article/pii/S1808869424001708
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Inflammatory and homeostatic roles of eosinophil subpopulations in chronic rhinosinusitis with nasal polyp pathogenesis
by: Kantapat Simmalee, et al.
Published: (2025-04-01)

Determining the Severity of Symptoms Among Patients with Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis Versus Non - Eosinophilic Chronic Rhinosinusitis with Nasal Polyposis at the Veterans Memorial Medical Center
by: Geoffrey John Hizon, et al.
Published: (2024-11-01)

Sirt5 affects the metabolic remodeling of eosinophils by negatively regulating the level of succinylation modification of Pkm2 in eosinophilic chronic rhinosinusitis
by: Shun‐Yu Wu, et al.
Published: (2025-03-01)

Atopic condition of the esophagus - eosinophilic esophagitis - literature review
by: Artur Pastuszka, et al.
Published: (2025-04-01)

Effective use of dupilumab for eosinophilic gastritis concomitant with severe asthma
by: Tomohito Takeshige, et al.
Published: (2024-12-01)

Lung function impairment and eosinophilia in patients with eosinophilic chronic rhinosinusitis
by: Yuki Sonoda, MD, et al.
Published: (2025-11-01)

Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results
by: Margaret H. Collins, et al.
Published: (2025-01-01)

Blood IgE and Eosinophils are not Reliable Predictors of Nasal Tissue Eosinophils in Chronic Rhinosinusitis with Nasal Polyposis
by: Judy Fan, et al.
Published: (2025-04-01)

Efficacy of Dupilumab in the Treatment of Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Szu-Hung Chu, et al.
Published: (2025-02-01)

Gαi1/3 signaling mediates IL-5-induced eosinophil activation and type 2 inflammation in eosinophilic chronic rhinosinusitis
by: Huanxia Xie, et al.
Published: (2025-01-01)

Vitamin D impedes eosinophil chemotaxis via inhibiting glycolysis-induced CCL26 expression in eosinophilic chronic rhinosinusitis with nasal polyps
by: Weiqiang Huang, et al.
Published: (2025-02-01)

Early Intervention with Mepolizumab, Corticosteroids, and Intravenous Immunoglobulin for Dupilumab-Triggered Eosinophilic Granulomatosis with Polyangiitis: A Case Report
by: Kaburaki S, et al.
Published: (2025-04-01)

IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients
by: Kazunori Kubota, et al.
Published: (2017-05-01)

Modern Possibilities of Usage Dupilumab in Children
by: Anna A. Kosova, et al.
Published: (2024-12-01)

[Artículo traducido] Alteraciones analíticas durante el tratamiento con dupilumab para la dermatitis atópica
by: D. Flor, et al.
Published: (2025-05-01)

Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma
by: Kenji Mizumura, et al.
Published: (2025-01-01)

Update on the Biological and Clinical Relevance of Mast Cells in Chronic Rhinosinusitis with Nasal Polyps
by: Luca Giovanni Locatello, et al.
Published: (2024-11-01)

Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)
by: Hiroyuki Nagase, et al.
Published: (2025-07-01)

The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)
by: Scott A. Hardison, et al.
Published: (2023-09-01)

The roles of nasal nitric oxide in diagnosis and endotypes of chronic rhinosinusitis with nasal polyps
by: Mengdi Zhu, et al.
Published: (2020-09-01)

Disease Burden and Spectrum of Symptoms That Impact Quality of Life in Pediatric Patients With Eosinophilic Esophagitis
by: Mirna Chehade, et al.
Published: (2024-01-01)

A multicenter, retrospective cohort study on the diagnosis, treatment and natural history of eosinophilic gastrointestinal disorders in the Netherlands
by: Milli Gupta, et al.
Published: (2025-03-01)

Consensus from European experts on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: Results from the OverSEA Delphi study
by: Claus Bachert, MD, PhD, et al.
Published: (2025-11-01)

Tissue eosinophil level as a predictor of control, severity, and recurrence of Chronic Rhinosinusitis with Nasal Polyps
by: Julissa Vizcarra-Melgar, et al.
Published: (2025-04-01)

A Patient With Eosinophilic Gastroenteritis Presenting With Severe Abdominal Pain
by: Sumona Islam, et al.
Published: (2024-12-01)

Investigation of Blood Count-Based Inflammatory Biomarkers as Predictors of Response to Dupilumab Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyps
by: Michael Habenbacher, et al.
Published: (2024-10-01)

Elevated MS4A2 and IgE interaction in nasal polyps contributing to poor postoperative prognosis in patients with eosinophilic chronic rhinosinusitis
by: Mika Nakano, et al.
Published: (2025-04-01)

Eosinophilic esophagitis with refractory response in a pediatric patient: A case report
by: Isamar carolina De Agrela-Mendes, et al.
Published: (2025-06-01)

Eosinophilic Gastroenteritis in the Setting of Colorectal Neoplasia
by: Yi Sien Koo, et al.
Published: (2020-07-01)

Endoscopic diagnosis and management of eosinophilic esophagitis
by: Fumio Tanaka, et al.
Published: (2025-04-01)

The Influence of Allergic Biomarkers in Chronic Rhinosinusitis Patients Who Underwent Functional Endoscopic Sinus Surgery
by: Lin‐Hsin Tsuei, et al.
Published: (2025-04-01)

Real-World Evaluation of Dupilumab in the Long-Term Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: A Focus on IL-4 and IL-13 Receptor Blockade
by: Nicola Lombardo, et al.
Published: (2024-12-01)

A Scoping Review of Eosinophilic Pneumonia and Antidepressants: An Association Not to Be Overlooked
by: Jaron Steiner, et al.
Published: (2025-01-01)

Therapeutic Effectiveness of SNOT 22-Based Interdose Interval Adjustment of Dupilumab for Chronic Rhinosinusitis With Nasal Polyps
by: So Yeon Yoon, et al.
Published: (2024-11-01)

The Association of Blood Eosinophils and Neutrophils Expressing Eosinophilic Surface Markers with the Severity and Outcome of COVID-19
by: Jun Wang, et al.
Published: (2024-12-01)

The role of CD24hiCD27+ regulatory B cells in human chronic rhinosinusitis with/without nasal polyps
by: Shiyu Tian, et al.
Published: (2024-11-01)

Eosinophil cytolysis with or without ETosis in four cases of human gastric cancer: a comparative ultrastructural study
by: Rosario Caruso, et al.
Published: (2025-04-01)

Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study
by: Lingyu Hu, et al.
Published: (2023-07-01)